Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma

Autor: Renata Ferrarotto, Luana G. Sousa, Lei Feng, Frank Mott, George Blumenschein, Mehmet Altan, Diana Bell, Flavia Bonini, Kaiyi Li, Mario L. Marques-Piubelli, Eduardo A. Dal Lago, Jason J. Johnson, Yoshitsugu Mitani, Myrna Godoy, Anna Lee, Michael Kupferman, Ehab Hanna, Bonnie S. Glisson, Yasir Elamin, Adel El-Naggar

Publikováno v: Journal of Clinical Oncology. 41:2843-2851

PURPOSE We conducted a phase II trial evaluating the efficacy of VEGFR inhibitor axitinib and PD-L1 inhibitor avelumab in patients with recurrent/metastatic adenoid cystic carcinoma (R/M ACC). PATIENTS AND METHODS Eligible patients had R/M ACC with p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3a2e3fd4daf39eb0ff4de2c56ccbb52d
https://doi.org/10.1200/jco.22.02221

Five lessons from a mid-level health manager intervention to increase uptake of tuberculosis prevention therapy in Uganda: 'it is a completely different thing to implement what you know.'

Autor: Johnson-Peretz J; Department of Obstetrics, Gynecology, & Reproductive Sciences, University of California, Oakland, CA, USA., Christian C; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA., Akatukwasa C; Infectious Diseases Research Collaboration (IDRC), Kampala, Uganda., Atwine F; Infectious Diseases Research Collaboration (IDRC), Kampala, Uganda., Kakande E; Infectious Diseases Research Collaboration (IDRC), Kampala, Uganda., Kamya MR; Infectious Diseases Research Collaboration (IDRC), Kampala, Uganda.; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda., Havlir DV; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA., Camlin CS; Department of Obstetrics, Gynecology, & Reproductive Sciences, University of California, Oakland, CA, USA.; Department of Medicine, University of California, San Francisco (UCSF), Center for AIDS Prevention Studies, San Francisco, CA, USA., Chamie G; Department of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California, San Francisco, CA, USA.

Publikováno v: Global health action [Glob Health Action] 2024 Dec 31; Vol. 17 (1), pp. 2427434. Date of Electronic Publication: 2024 Nov 18.

A Simplified Staged Left Ventricular Recruitment Strategy to Achieve Biventricular Repair in a Neonate With Hypoplastic Left Heart Variant.

Autor: Philip R; Division of Pediatric Cardiology and Cardiac Surgery, The Heart Institute, Le Bonheur Children's Hospital, Memphis, TN, USA.; University of Tennessee Health Science Center, Memphis, TN, USA., Johnson J; Division of Pediatric Cardiology and Cardiac Surgery, The Heart Institute, Le Bonheur Children's Hospital, Memphis, TN, USA.; University of Tennessee Health Science Center, Memphis, TN, USA., Naik RJ; Division of Pediatric Cardiology and Cardiac Surgery, The Heart Institute, Le Bonheur Children's Hospital, Memphis, TN, USA.; University of Tennessee Health Science Center, Memphis, TN, USA., Perkins AA; University of Tennessee Health Science Center, Memphis, TN, USA., Sathanandam S; Division of Pediatric Cardiology and Cardiac Surgery, The Heart Institute, Le Bonheur Children's Hospital, Memphis, TN, USA.; University of Tennessee Health Science Center, Memphis, TN, USA., Knott-Craig CJ; Division of Pediatric Cardiology and Cardiac Surgery, The Heart Institute, Le Bonheur Children's Hospital, Memphis, TN, USA.; University of Tennessee Health Science Center, Memphis, TN, USA., Boston U; Division of Pediatric Cardiology and Cardiac Surgery, The Heart Institute, Le Bonheur Children's Hospital, Memphis, TN, USA.; University of Tennessee Health Science Center, Memphis, TN, USA.

Publikováno v: World journal for pediatric & congenital heart surgery [World J Pediatr Congenit Heart Surg] 2024 Nov; Vol. 15 (6), pp. 848-851. Date of Electronic Publication: 2024 Aug 21.

A/B Testing of User Enrollment Forms to Enhance Diversity in the Biomedical Workforce via the National Research Mentoring Network: User-Centered Design Case Study.

Autor: Syed TA; University of Texas Health Science Center at Houston, Houston, TX, United States., Thompson EL; University of Texas Health Science Center at San Antonio, San Antonio, TX, United States., Johnson J; University of Texas Health Science Center at Houston, Houston, TX, United States., Latif Z; Northwestern University, Evanston, IL, United States., Kennedy N; Vanderbilt University Medical Center, Nashville, TN, United States., Javier D; University of North Texas Health Science Center at Fort Worth, Fort Worth, TX, United States., Stinson K; University of Texas Health Science Center at Houston, Houston, TX, United States., Vishwanatha JK; University of North Texas Health Science Center at Fort Worth, Fort Worth, TX, United States.

Publikováno v: JMIR human factors [JMIR Hum Factors] 2024 Jul 02; Vol. 11, pp. e54532. Date of Electronic Publication: 2024 Jul 02.

International Multi-Specialty Expert Physician Preoperative Identification of Extranodal Extension n Oropharyngeal Cancer Patients using Computed Tomography: Prospective Blinded Human Inter-Observer Performance Evaluation.

Autor: Sahin O; The University of Texas MD Anderson Cancer Center, Houston, USA., Kamel S; The University of Texas MD Anderson Cancer Center, Houston, USA., Wahid KA; The University of Texas MD Anderson Cancer Center, Houston, USA., Dede C; The University of Texas MD Anderson Cancer Center, Houston, USA., Taku N; The University of Texas MD Anderson Cancer Center, Houston, USA., He R; The University of Texas MD Anderson Cancer Center, Houston, USA., Naser MA; The University of Texas MD Anderson Cancer Center, Houston, USA., Sharafi S; The University of Texas MD Anderson Cancer Center, Houston, USA., Mäkitie A; University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Kann BH; Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Kaski K; Aalto University, Espoo, Finland., Sahlsten J; Aalto University, Espoo, Finland., Jaskari J; Aalto University, Espoo, Finland., Amit M; The University of Texas MD Anderson Cancer Center, Houston, USA., Chronowski GM; The University of Texas MD Anderson Cancer Center, Houston, USA., Diaz EM Jr; The University of Texas MD Anderson Cancer Center, Houston, USA., Garden AS; The University of Texas MD Anderson Cancer Center, Houston, USA., Goepfert RP; The University of Texas MD Anderson Cancer Center, Houston, USA., Guenette JP; Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Gunn GB; The University of Texas MD Anderson Cancer Center, Houston, USA., Hirvonen J; Tampere University, Faculty of Medicine and Health Technology and Tampere University Hospital, Tampere, Finland., Hoebers F; Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Hutcheson KA; The University of Texas MD Anderson Cancer Center, Houston, USA., Guha-Thakurta N; The University of Texas MD Anderson Cancer Center, Houston, USA., Johnson J; The University of Texas MD Anderson Cancer Center, Houston, USA., Kaya D; The University of Texas MD Anderson Cancer Center, Houston, USA., Khanpara SD; The University of Texas MD Anderson Cancer Center, Houston, USA., Nyman K; University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Lai SY; The University of Texas MD Anderson Cancer Center, Houston, USA., Lango M; The University of Texas MD Anderson Cancer Center, Houston, USA., Learned KO; The University of Texas MD Anderson Cancer Center, Houston, USA., Lee A; The University of Texas MD Anderson Cancer Center, Houston, USA., Lewis CM; The University of Texas MD Anderson Cancer Center, Houston, USA., Maniakas A; The University of Texas MD Anderson Cancer Center, Houston, USA., Moreno AC; The University of Texas MD Anderson Cancer Center, Houston, USA., Myers JN; The University of Texas MD Anderson Cancer Center, Houston, USA., Phan J; The University of Texas MD Anderson Cancer Center, Houston, USA., Pytynia KB; The University of Texas MD Anderson Cancer Center, Houston, USA., Rosenthal DI; The University of Texas MD Anderson Cancer Center, Houston, USA., Sandulache VC; Department of Otolaryngology Head and Neck Surgery, Baylor College of Medicine, Houston, USA., Schellingerhout D; The University of Texas MD Anderson Cancer Center, Houston, USA., Shah SJ; The University of Texas MD Anderson Cancer Center, Houston, USA., Sikora AG; The University of Texas MD Anderson Cancer Center, Houston, USA., Mohamed ASR; The University of Texas MD Anderson Cancer Center, Houston, USA.; Department of Otolaryngology Head and Neck Surgery, Baylor College of Medicine, Houston, USA., Chen MM; The University of Texas MD Anderson Cancer Center, Houston, USA., Fuller CD; The University of Texas MD Anderson Cancer Center, Houston, USA.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Jun 08. Date of Electronic Publication: 2024 Jun 08.